Medicon Valley Alliance together with Lund Stem Cell Center, Lund University have the pleasure to invite you the Medicon Valley Alliance R&D Network meeting on 24th of November, 2021 in Lund.
Cell and gene therapies are being widely accepted as one of the most transformative innovative trends in biopharmaceuticals. Cell and gene therapies are expected to increasingly shape the medical treatment and diagnosis across a wide range of diseases. Currently there are only a few approved cell and gene therapies on the market which shows that we are still in the early stages of clinical use of these treatments. The global cell and gene therapy market was valued at $4.4 billion in 2020 and is expected to reach $15.5 billion in 2025.
Despite the clinical, and commercial, potential in cell-based therapies the whole process from concept to commercialisation is a very demanding and challenging with a constant need for technological improvements, managing supply chain and manufacturing operations, regulatory concerns and enabling patient access.
In this MVA R&D Network meeting, hosted by Lund Stem Cell Center, leading researchers and industry players from the region will share their latest findings as well as discussing opportunities and challenges in developing ground-breaking cell and gene therapies.
Date: Wednesday 24th of November, 2021
Time: 12.30 – 16.30
Venue: Aulan (Auditorium), Skåne University Hospital Lund, Entrégatan 7, Lund, Sweden
Host: Lund Stem Cell Center
Moderator: Johan Flygare, Associate Professor, Lund Stem Cell Center
PROGRAM
| 12.30 – 13.00 | Arrival and registration |
| 13.00 – 13.10 | Welcome and introduction Anette Steenberg, CEO, Medicon Valley Alliance Johan Flygare, Associate Professor, Lund Stem Cell Center |
| 13.10 – 13.15 | How to patent stem cells Peter Holm, Partner, European Patent Attorney, HØIBERG |
| 13.15 – 13.30 | Introduction to cell and gene Therapies and the hospital perspective Stefan Jovinge, Research Director, Skåne University Hospitals, Region Skåne |
| 13.30 – 13.45 | New approaches to enhancing the production of human liver and pancreatic cells from pluripotent stem cells Joshua M. Brickman, Professor & Interim Executive Director, Novo Nordisk Foundation Center for Stem Cell Biology – DanStem |
| 13.45 – 14.00 | Development of a cancer gene therapy based on cellular reprogramming Filipe Pereira, Associate Professor, Lund University & Co – Founder of Asgard Therapeutics |
| 14.00 – 14.15 | Germline stem cell-based therapies for fertility preservation and restoration Eva Hoffman, Professor, University of Copenhagen & Fertility restoration consortium |
| 14.15 – 14.40 | Break |
| 14.40 – 14.55 | Bringing a pluripotent cell product to clinical trial for Parkinson’s Disease Malin Parmar, Professor, Lund University |
| 14.55 – 15.10 | Cell Therapy R&D in Novo Nordisk – Industry perspective and challenges Louise Winkel, Director, Cell Formulation & Delivery, Novo Nordisk |
| 15.10 – 15.25 | Amniotics – Perspective on ATMP manufacturing Jan Talts, COO, Amniotics AB |
| 15.25 – 15.40 | Karolinska Cell Therapy Center – an Infrastructure for Translation of ATMPs Into the Clinic Pontus Blomberg, Director Karolinska Cell Therapy Center |
| 15.40 – 16.00 | Panel discussion and Q&A All speakers, moderated by Johan Flygare, Associate Professor, Lund Stem Cell Center |
| 16.00 – 16.30 | Networking |
Registration ends on 19th of November.
The MVA R&D Network
The Medicon Valley Alliance R&D Network is a professional and social network for C-level R&D executives (CSOs, CMOs, VPs), university professors and PIs, and top-level managers in the hospital sector. The network focuses on sharing best practice and experiences, as well as discussing current challenges for industry-academia collaboration and the commercialization of R&D in the Medicon Valley region, such as how we can strengthen collaboration and knowledge-sharing between academia and industry to stimulate start-up, scale-up, commercialization and growth and wat is required to turn great science into successful innovations.
Joining the network is free of charge but is limited to Medicon Valley Alliance members. Non-member organizations and companies are welcome to attend one network event to evaluate the relevance in joining the network. For more information please contact Sofia Norås sn@mva.org
| Host | Sponsor of the event |
 |
 |
| MVA R&D Network is managed by | In collaboration with | |
 |
 |
 |